真实世界证据可提高决策质量。
Real-world evidence enhances decision making.
机构信息
University of Arizona College of Pharmacy, Tucson.
出版信息
J Manag Care Spec Pharm. 2020 Dec;26(12):1612-1614. doi: 10.18553/jmcp.2020.26.12.1612a.
Abstract
No funding supported the writing of this commentary. The author has nothing to disclose.
摘要
本评论文章的撰写未获得任何资金支持。作者无利益披露。
相似文献
1
Real-world evidence enhances decision making.
J Manag Care Spec Pharm. 2020 Dec;26(12):1612-1614. doi: 10.18553/jmcp.2020.26.12.1612a.
2
Can the learning health care system be educated with observational data?
JAMA. 2014 Jul;312(2):129-30. doi: 10.1001/jama.2014.4364.
3
When Can We Rely on Real-World Evidence to Evaluate New Medical Treatments?
Clin Pharmacol Ther. 2022 Jan;111(1):30-34. doi: 10.1002/cpt.2253. Epub 2021 May 19.
4
Information technology innovation: the power and perils of big data.
Br J Anaesth. 2015 Sep;115(3):339-42. doi: 10.1093/bja/aev154. Epub 2015 Jun 1.
5
Is Real-World Evidence Used in P&T Monographs and Therapeutic Class Reviews?
J Manag Care Spec Pharm. 2020 Dec;26(12):1604-1611. doi: 10.18553/jmcp.2020.26.12.1604.
6
Using Health System Data for Improvement Science: Getting Started.
AACN Adv Crit Care. 2018 Fall;29(3):348-353. doi: 10.4037/aacnacc2018653.
7
The '70% claim': what is the evidence base?
Ann Clin Biochem. 2011 Nov;48(Pt 6):487-8. doi: 10.1258/acb.2011.011177.
8
Can Digital Health Enable Higher Quality Real-World Evidence-Based Decisions?
Clin Pharmacol Ther. 2019 Jul;106(1):45-46. doi: 10.1002/cpt.1440. Epub 2019 Apr 23.
9
Taking a byte out of big data.
J Am Dent Assoc. 2015 Nov;146(11):793-4. doi: 10.1016/j.adaj.2015.09.002.
10
[All evidence is real world evidence.].
Recenti Prog Med. 2019 Apr;110(4):165-167. doi: 10.1701/3154.31342.
本文引用的文献
1
Awareness, Knowledge, and Utility of RCT Data vs RWE: Results From a Survey of US Cardiologists: Real-world Evidence in Clinical Decision Making.
Clin Med Insights Cardiol. 2020 Sep 2;14:1179546820953410. doi: 10.1177/1179546820953410. eCollection 2020.
2
Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing-Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative.
Value Health. 2020 Sep;23(9):1128-1136. doi: 10.1016/j.jval.2020.04.002.
3
Susan G. Komen Big Data for Breast Cancer Initiative: How Patient Advocacy Organizations Can Facilitate Using Big Data to Improve Patient Outcomes.
JCO Precis Oncol. 2019 Sep 12;3. doi: 10.1200/PO.19.00184. eCollection 2019.
4
Harnessing Real-World Data to Inform Decision-Making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS).
Front Neurol. 2020 Aug 7;11:632. doi: 10.3389/fneur.2020.00632. eCollection 2020.
5
Weighing the Benefits and Risks of Proliferating Observational Treatment Assessments: Observational Cacophony, Randomized Harmony.
JAMA. 2020 Aug 18;324(7):625-626. doi: 10.1001/jama.2020.13319.
6
Treatment Patterns and Costs in Biologic DMARD-Naive Patients with Rheumatoid Arthritis Initiating Etanercept or Adalimumab with or Without Methotrexate.
J Manag Care Spec Pharm. 2020 Mar;26(3):285-294. doi: 10.18553/jmcp.2020.26.3.285.
7
Application of a Graphical Depiction of Longitudinal Study Designs to Managed Care Pharmacy Research.
J Manag Care Spec Pharm. 2020 Mar;26(3):268-274. doi: 10.18553/jmcp.2020.26.3.268.
8
Adherence and Persistence with DPP-4 Inhibitors Versus Pioglitazone in Type 2 Diabetes Patients with Chronic Kidney Disease: A Retrospective Claims Database Analysis.
J Manag Care Spec Pharm. 2020 Jan;26(1):67-75. doi: 10.18553/jmcp.2020.26.1.67.
9
Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States.
Circulation. 2018 Oct 9;138(15):1519-1529. doi: 10.1161/CIRCULATIONAHA.118.035418.
10
Real-World Evidence: Useful in the Real World of US Payer Decision Making? How? When? And What Studies?
Value Health. 2018 Mar;21(3):326-333. doi: 10.1016/j.jval.2017.08.3013. Epub 2017 Oct 18.
Zotero 插件